Table 1.
Correlation Between miR-429 Expression and Clinical Characteristics in CRC
| Patients (n) | ||||
|---|---|---|---|---|
| Variables | Total | mir-429 Low | Low expression rate (%) | P value (Pearson x2) |
| Age (median=56) | *0.001 | |||
| <56 | 51 | 42 | 82.4 | |
| >=56 | 52 | 27 | 51.9 | |
| Gender | 0.0553 | |||
| Male | 59 | 35 | 59.3 | |
| Female | 44 | 34 | 77.2 | |
| Tumor size (median=4.2cm) | 0.364 | |||
| <4.2cm | 51 | 32 | 62.7 | |
| >=4.2cm | 52 | 37 | 71.5 | |
| Differentiation | *0.019 | |||
| Well/moderate | 88 | 55 | 62.5 | |
| Poorly | 15 | 14 | 93.3 | |
| Location | ||||
| Primary tumor (CA) | 103 | 69 | 67.0 | |
| Adjacent mucosa (CB) | 103 | 49 | 47.5 | *0.0048 |
| Distant normal mucosa | 103 | 48 | 46.6 | *0.0031 |
| Lymphatic metastasis | ||||
| No | 48 | 31 | 64.6 | |
| Yes | 55 | 38 | 69.1 | 0.6275 |
| TNM stage | ||||
| CC (5cm) | 103 | 48 | 46.6 | |
| I CA | 3 | 2 | 66.7 | 0.4925 |
| II CA | 45 | 29 | 64.4 | *0.0456 |
| III CA | 30 | 22 | 73.3 | *0.0098 |
| IV CA | 25 | 16 | 64.0 | 0.1185 |
*
P<0.05.